LAUREN KNUELLE: Open Payments
NPI 1881359818 · OVIEDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,559 in 82 payments from 15 companies in 2025. Trend: 2023 $78 · 2024 $226 · 2025 $1,559
Food & beverage: $1,549Education: $9
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $304 |
| ABBVIE INC. | 17 | $273 |
| Janssen Biotech, Inc. | 17 | $236 |
| Madrigal Pharmaceuticals | 8 | $206 |
| Ardelyx, Inc. | 5 | $108 |
| VIVUS LLC | 4 | $85 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $79 |
| Ipsen Biopharmaceuticals, Inc | 2 | $54 |
| Lilly USA, LLC | 3 | $54 |
| Aimmune Therapeutics, Inc. | 2 | $51 |
Products named: ENTYVIO, TREMFYA, REZDIFFRA, IBSRELA, PANCREAZE, XIFAXAN, LINZESS, RINVOQ.
Industry payments across FL — which companies pay providers there.
